{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:27:27Z","timestamp":1784046447122,"version":"3.55.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01 HL021796"],"award-info":[{"award-number":["5R01 HL021796"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01 HL086741"],"award-info":[{"award-number":["2R01 HL086741"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12967-017-1270-0","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T12:50:02Z","timestamp":1501246202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations"],"prefix":"10.1186","volume":"15","author":[{"given":"Christoph S.","family":"Nabzdyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Pradhan-Nabzdyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.","family":"LoGerfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"1270_CR1","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1038\/mtna.2015.23","volume":"4","author":"JK Lam","year":"2015","unstructured":"Lam JK, et al. siRNA versus miRNA as therapeutics for gene silencing. Mol Ther Nucleic Acids. 2015;4:e252.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"1270_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.1064703","volume":"17","author":"JG Doench","year":"2003","unstructured":"Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs. Genes Dev. 2003;17(4):438\u201342.","journal-title":"Genes Dev"},{"issue":"7","key":"1270_CR3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.115.308237","volume":"118","author":"C Gareri","year":"2016","unstructured":"Gareri C, De Rosa S, Indolfi C. MicroRNAs for restenosis and thrombosis after vascular injury. Circ Res. 2016;118(7):1170\u201384.","journal-title":"Circ Res"},{"issue":"4","key":"1270_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cvr\/cvn156","volume":"79","author":"C Urbich","year":"2008","unstructured":"Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. 2008;79(4):581\u20138.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"1270_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/CIRCRESAHA.107.163147","volume":"101","author":"MV Latronico","year":"2007","unstructured":"Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res. 2007;101(12):1225\u201336.","journal-title":"Circ Res"},{"issue":"5808","key":"1270_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1136235","volume":"315","author":"HW Hwang","year":"2007","unstructured":"Hwang HW, Wentzel EA, Mendell JT. A hexanucleotide element directs microRNA nuclear import. Science. 2007;315(5808):97\u2013100.","journal-title":"Science"},{"issue":"98","key":"1270_CR7","first-page":"125","volume":"18","author":"L Pradhan-Nabzdyk","year":"2014","unstructured":"Pradhan-Nabzdyk L, et al. Current siRNA targets in the prevention and treatment of intimal hyperplasia. Discov Med. 2014;18(98):125\u201332.","journal-title":"Discov Med"},{"issue":"95","key":"1270_CR8","first-page":"233","volume":"17","author":"L Pradhan-Nabzdyk","year":"2014","unstructured":"Pradhan-Nabzdyk L, et al. Current siRNA targets in atherosclerosis and aortic aneurysm. Discov Med. 2014;17(95):233\u201346.","journal-title":"Discov Med"},{"key":"1270_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1479-5876-9-48","volume":"9","author":"CS Nabzdyk","year":"2011","unstructured":"Nabzdyk CS, et al. High throughput RNAi assay optimization using adherent cell cytometry. J Transl Med. 2011;9:48.","journal-title":"J Transl Med"},{"issue":"2","key":"1270_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbrc.2012.07.078","volume":"425","author":"CS Nabzdyk","year":"2012","unstructured":"Nabzdyk CS, et al. Differential susceptibility of human primary aortic and coronary artery vascular cells to RNA interference. Biochem Biophys Res Commun. 2012;425(2):261\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1270_CR11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jvs.2010.06.169","volume":"52","author":"ND Andersen","year":"2010","unstructured":"Andersen ND, et al. Endothelial cells are susceptible to rapid siRNA transfection and gene silencing ex vivo. J Vasc Surg. 2010;52(6):1608\u201315.","journal-title":"J Vasc Surg"},{"issue":"3","key":"1270_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jamcollsurg.2006.12.029","volume":"204","author":"ND Andersen","year":"2007","unstructured":"Andersen ND, et al. Comparison of gene silencing in human vascular cells using small interfering RNAs. J Am Coll Surg. 2007;204(3):399\u2013408.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"1270_CR13","doi-asserted-by":"publisher","first-page":"H1841","DOI":"10.1152\/ajpheart.00089.2011","volume":"301","author":"CS Nabzdyk","year":"2011","unstructured":"Nabzdyk CS, et al. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2011;301(5):H1841\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"1270_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2337\/db06-1418","volume":"56","author":"B You","year":"2007","unstructured":"You B, et al. Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia. Diabetes. 2007;56(5):1445\u201353.","journal-title":"Diabetes"},{"issue":"1","key":"1270_CR15","first-page":"58","volume":"87","author":"XH Hu","year":"2007","unstructured":"Hu XH, et al. Effect of RNA interference targeting mammalian target of rapamycin on the proliferation of vascular smooth muscle cell and the intimal hyperplasia. Zhonghua Yi Xue Za Zhi. 2007;87(1):58\u201362.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"9","key":"1270_CR16","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/01.ATV.0000235724.11299.76","volume":"26","author":"PM Winter","year":"2006","unstructured":"Winter PM, et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26(9):2103\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1270_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/01.RES.25.6.677","volume":"25","author":"H Wolinsky","year":"1969","unstructured":"Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals. Deviation of man from the usual pattern. Circ Res. 1969;25(6):677\u201386.","journal-title":"Circ Res"},{"key":"1270_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2016.09.067","volume":"254","author":"JN Jones Buie","year":"2016","unstructured":"Jones Buie JN, et al. The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis. 2016;254:271\u201381.","journal-title":"Atherosclerosis"},{"issue":"7","key":"1270_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/01.RES.87.7.574","volume":"87","author":"JL Hall","year":"2000","unstructured":"Hall JL, et al. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circ Res. 2000;87(7):574\u201380.","journal-title":"Circ Res"},{"issue":"1","key":"1270_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/cvr\/cvw039","volume":"110","author":"SM Welten","year":"2016","unstructured":"Welten SM, et al. The multifactorial nature of microRNAs in vascular remodelling. Cardiovasc Res. 2016;110(1):6\u201322.","journal-title":"Cardiovasc Res"},{"issue":"22","key":"1270_CR21","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/eurheartj\/ehw047","volume":"37","author":"DM Leistner","year":"2016","unstructured":"Leistner DM, et al. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics. Eur Heart J. 2016;37(22):1738\u201349.","journal-title":"Eur Heart J"},{"key":"1270_CR22","doi-asserted-by":"crossref","unstructured":"Eken SM, et al. MicroRNA-210 enhances fibrous cap stability in advanced atherosclerotic lesions. Circ Res. 2016.","DOI":"10.1161\/CIRCRESAHA.116.309318"},{"issue":"4","key":"1270_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1517\/14728222.2014.989835","volume":"19","author":"X Loyer","year":"2015","unstructured":"Loyer X, et al. MicroRNAs as therapeutic targets in atherosclerosis. Expert Opin Ther Targets. 2015;19(4):489\u201396.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"1270_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jss.2014.05.045","volume":"192","author":"H Cao","year":"2014","unstructured":"Cao H, et al. Upregulation of let-7a inhibits vascular smooth muscle cell proliferation in vitro and in vein graft intimal hyperplasia in rats. J Surg Res. 2014;192(1):223\u201333.","journal-title":"J Surg Res"},{"issue":"1\u20132","key":"1270_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11010-015-2614-9","volume":"412","author":"KG Maier","year":"2016","unstructured":"Maier KG, et al. Thrombospondin-1 differentially regulates microRNAs in vascular smooth muscle cells. Mol Cell Biochem. 2016;412(1\u20132):111\u20137.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"1270_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","volume":"43","author":"MS Conte","year":"2006","unstructured":"Conte MS, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43(4):742\u201351 (discussion 751).","journal-title":"J Vasc Surg"},{"issue":"1","key":"1270_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/153857440503900102","volume":"39","author":"MS Conte","year":"2005","unstructured":"Conte MS, et al. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovasc Surg. 2005;39(1):15\u201323.","journal-title":"Vasc Endovasc Surg"},{"issue":"1","key":"1270_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jss.2015.07.025","volume":"199","author":"LM Bools","year":"2015","unstructured":"Bools LM, et al. Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells. J Surg Res. 2015;199(1):266\u201373.","journal-title":"J Surg Res"},{"key":"1270_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12864-015-2267-9","volume":"17","author":"NA Raof","year":"2016","unstructured":"Raof NA, et al. The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells. BMC Genom. 2016;17:20.","journal-title":"BMC Genom"},{"key":"1270_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1746-6148-9-54","volume":"9","author":"N Isayama","year":"2013","unstructured":"Isayama N, Matsumura G, Yamazaki K. Comparison of vascular smooth muscle cells in canine great vessels. BMC Vet Res. 2013;9:54.","journal-title":"BMC Vet Res"},{"key":"1270_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6793-11-9","volume":"11","author":"JH Lillvis","year":"2011","unstructured":"Lillvis JH, et al. Regional expression of HOXA4 along the aorta and its potential role in human abdominal aortic aneurysms. BMC Physiol. 2011;11:9.","journal-title":"BMC Physiol"},{"issue":"31","key":"1270_CR32","doi-asserted-by":"publisher","first-page":"10947","DOI":"10.1073\/pnas.0504934102","volume":"102","author":"A Drusco","year":"2005","unstructured":"Drusco A, et al. Knockout mice reveal a tumor suppressor function for Testin. Proc Natl Acad Sci USA. 2005;102(31):10947\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1270_CR33","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/hmg\/ddr574","volume":"21","author":"SR Archacki","year":"2012","unstructured":"Archacki SR, et al. Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease. Hum Mol Genet. 2012;21(6):1364\u201373.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1270_CR34","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/01.ATV.0000208185.16371.97","volume":"26","author":"DX Deng","year":"2006","unstructured":"Deng DX, et al. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli. Arterioscler Thromb Vasc Biol. 2006;26(5):1058\u201365.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"1270_CR35","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jvs.2007.01.061","volume":"45","author":"NA Turner","year":"2007","unstructured":"Turner NA, et al. Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells. J Vasc Surg. 2007;45(5):1022\u20138.","journal-title":"J Vasc Surg"},{"issue":"1","key":"1270_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/jsre.2002.6399","volume":"104","author":"PL Faries","year":"2002","unstructured":"Faries PL, et al. Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells. J Surg Res. 2002;104(1):22\u20138.","journal-title":"J Surg Res"},{"issue":"5","key":"1270_CR37","doi-asserted-by":"publisher","first-page":"H1173","DOI":"10.1152\/ajpheart.00411.2011","volume":"302","author":"A Chanakira","year":"2012","unstructured":"Chanakira A, et al. Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFR-beta and VEGFR-2 expression. Am J Physiol Heart Circ Physiol. 2012;302(5):H1173\u201384.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7256","key":"1270_CR38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"KR Cordes","year":"2009","unstructured":"Cordes KR, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460(7256):705\u201310.","journal-title":"Nature"},{"key":"1270_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.phrs.2013.04.003","volume":"75","author":"S Albinsson","year":"2013","unstructured":"Albinsson S, Sward K. Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol Res. 2013;75:28\u201336.","journal-title":"Pharmacol Res"},{"issue":"11","key":"1270_CR40","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1161\/CIRCRESAHA.116.305178","volume":"116","author":"M Climent","year":"2015","unstructured":"Climent M, et al. TGFbeta triggers miR-143\/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization. Circ Res. 2015;116(11):1753\u201364.","journal-title":"Circ Res"},{"issue":"4 Suppl","key":"1270_CR41","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1097\/01.CCM.0000057847.32590.C1","volume":"31","author":"WC Aird","year":"2003","unstructured":"Aird WC. Endothelial cell heterogeneity. Crit Care Med. 2003;31(4 Suppl):S221\u201330.","journal-title":"Crit Care Med"},{"issue":"1","key":"1270_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10558-009-9089-9","volume":"10","author":"EJ Weinberg","year":"2010","unstructured":"Weinberg EJ, et al. Hemodynamic environments from opposing sides of human aortic valve leaflets evoke distinct endothelial phenotypes in vitro. Cardiovasc Eng. 2010;10(1):5\u201311.","journal-title":"Cardiovasc Eng"},{"issue":"1","key":"1270_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12861-016-0133-x","volume":"16","author":"K Beets","year":"2016","unstructured":"Beets K, et al. BMP-SMAD signalling output is highly regionalized in cardiovascular and lymphatic endothelial networks. BMC Dev Biol. 2016;16(1):34.","journal-title":"BMC Dev Biol"},{"key":"1270_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cytogfr.2015.12.005","volume":"27","author":"GA de Vinuesa","year":"2016","unstructured":"de Vinuesa GA. BMP signaling in vascular biology and dysfunction. Cytokine Growth Factor Rev. 2016;27:65\u201379.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"1270_CR45","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1161\/ATVBAHA.114.303425","volume":"34","author":"S Kumar","year":"2014","unstructured":"Kumar S, et al. Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs. Arterioscler Thromb Vasc Biol. 2014;34(10):2206\u201316.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"1270_CR46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1124\/dmd.106.009555","volume":"34","author":"FM van de Water","year":"2006","unstructured":"van de Water FM, et al. Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos. 2006;34(8):1393\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"1270_CR47","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","volume":"97","author":"C Wahlestedt","year":"2000","unstructured":"Wahlestedt C, et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci USA. 2000;97(10):5633\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1270_CR48","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1158\/1535-7163.MCT-06-0195","volume":"6","author":"OR Mook","year":"2007","unstructured":"Mook OR, et al. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo. Mol Cancer Ther. 2007;6(3):833\u201343.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1270_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","volume":"114","author":"H Lv","year":"2006","unstructured":"Lv H, et al. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006;114(1):100\u20139.","journal-title":"J Control Release"},{"issue":"2","key":"1270_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrd2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8(2):129\u201338.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1270_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1023\/A:1020134521778","volume":"22","author":"T Ishida","year":"2002","unstructured":"Ishida T, Harashima H, Kiwada H. Liposome clearance. Biosci Rep. 2002;22(2):197\u2013224.","journal-title":"Biosci Rep"},{"issue":"3","key":"1270_CR52","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1124\/jpet.104.078113","volume":"312","author":"SC Semple","year":"2005","unstructured":"Semple SC, et al. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J Pharmacol Exp Ther. 2005;312(3):1020\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"1270_CR53","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"G Bozzuto","year":"2015","unstructured":"Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975\u201399.","journal-title":"Int J Nanomed"},{"key":"1270_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/0-306-46803-4_6","volume":"10","author":"R Gref","year":"1997","unstructured":"Gref R, et al. Poly(ethylene glycol)-coated nanospheres: potential carriers for intravenous drug administration. Pharm Biotechnol. 1997;10:167\u201398.","journal-title":"Pharm Biotechnol"},{"issue":"2\u20133","key":"1270_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","volume":"16","author":"R Gref","year":"1995","unstructured":"Gref R, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev. 1995;16(2\u20133):215\u201333.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"1270_CR56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","volume":"40","author":"JM Harris","year":"2001","unstructured":"Harris JM, Martin NE, Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet. 2001;40(7):539\u201351.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1270_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jconrel.2006.02.012","volume":"112","author":"J Heyes","year":"2006","unstructured":"Heyes J, et al. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. J Control Release. 2006;112(2):280\u201390.","journal-title":"J Control Release"},{"issue":"9","key":"1270_CR58","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1016\/j.biomaterials.2013.12.026","volume":"35","author":"CS Nabzdyk","year":"2014","unstructured":"Nabzdyk CS, et al. Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA complexes released from dip-coated electrospun poly(ethylene terephthalate) grafts. Biomaterials. 2014;35(9):3071\u20139.","journal-title":"Biomaterials"},{"key":"1270_CR59","doi-asserted-by":"crossref","unstructured":"Bodewes TC, et al. Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model. FASEB J. 2016.","DOI":"10.1096\/fj.201600501r"},{"issue":"8","key":"1270_CR60","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s11095-012-0750-4","volume":"29","author":"D Lee","year":"2012","unstructured":"Lee D, et al. Bioreducible crosslinked polyelectrolyte complexes for MMP-2 siRNA delivery into human vascular smooth muscle cells. Pharm Res. 2012;29(8):2213\u201324.","journal-title":"Pharm Res"},{"issue":"4","key":"1270_CR61","doi-asserted-by":"publisher","first-page":"e0122581","DOI":"10.1371\/journal.pone.0122581","volume":"10","author":"E Nicoli","year":"2015","unstructured":"Nicoli E, et al. Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes. PLoS ONE. 2015;10(4):e0122581.","journal-title":"PLoS ONE"},{"issue":"5","key":"1270_CR62","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.nano.2014.03.006","volume":"10","author":"J Shi","year":"2014","unstructured":"Shi J, et al. Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine. 2014;10(5):897\u2013900.","journal-title":"Nanomedicine"},{"key":"1270_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2015.05.261","volume":"210","author":"JM McLendon","year":"2015","unstructured":"McLendon JM, et al. Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension. J Control Release. 2015;210:67\u201375.","journal-title":"J Control Release"},{"issue":"11","key":"1270_CR64","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/ppsc.201400036","volume":"31","author":"S Tripathy","year":"2014","unstructured":"Tripathy S, et al. High density lipoprotein nanoparticles deliver RNAi to endothelial cells to inhibit angiogenesis. Part Part Syst Charact. 2014;31(11):1141\u201350.","journal-title":"Part Part Syst Charact"},{"key":"1270_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jconrel.2014.07.056","volume":"195","author":"D Haussecker","year":"2014","unstructured":"Haussecker D. Current issues of RNAi therapeutics delivery and development. J Control Release. 2014;195:49\u201354.","journal-title":"J Control Release"},{"issue":"7","key":"1270_CR66","first-page":"698","volume":"5","author":"P Lu","year":"2012","unstructured":"Lu P, et al. Effect of GPE-AGT nanoparticle shRNA transfection system mediated RNAi on early atherosclerotic lesion. Int J Clin Exp Pathol. 2012;5(7):698\u2013706.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"1270_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jbm.820050305","volume":"5","author":"RK Kulkarni","year":"1971","unstructured":"Kulkarni RK, et al. Biodegradable poly(lactic acid) polymers. J Biomed Mater Res. 1971;5(3):169\u201381.","journal-title":"J Biomed Mater Res"},{"issue":"44","key":"1270_CR68","doi-asserted-by":"publisher","first-page":"445101","DOI":"10.1088\/0957-4484\/22\/44\/445101","volume":"22","author":"A Mukerjee","year":"2011","unstructured":"Mukerjee A, et al. Efficient nanoparticle mediated sustained RNA interference in human primary endothelial cells. Nanotechnology. 2011;22(44):445101.","journal-title":"Nanotechnology"},{"issue":"14","key":"1270_CR69","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1016\/j.biomaterials.2014.02.009","volume":"35","author":"X Liu","year":"2014","unstructured":"Liu X, et al. Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector. Biomaterials. 2014;35(14):4401\u201316.","journal-title":"Biomaterials"},{"issue":"3","key":"1270_CR70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000320567","volume":"26","author":"J Yang","year":"2010","unstructured":"Yang J, et al. Lentivirus-mediated RNAi targeting CREB binding protein attenuates neointimal formation and promotes re-endothelialization in balloon injured rat carotid artery. Cell Physiol Biochem. 2010;26(3):441\u20138.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"1270_CR71","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1007\/s11033-010-9977-5","volume":"38","author":"G Chen","year":"2011","unstructured":"Chen G, et al. Construction of NF-kappaB-targeting RNAi adenovirus vector and the effect of NF-kappaB pathway on proliferation and apoptosis of vascular endothelial cells. Mol Biol Rep. 2011;38(5):3089\u201394.","journal-title":"Mol Biol Rep"},{"key":"1270_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-1-59259-879-3_9","volume":"112","author":"H Kasahara","year":"2005","unstructured":"Kasahara H, Aoki H. Gene silencing using adenoviral RNAi vector in vascular smooth muscle cells and cardiomyocytes. Methods Mol Med. 2005;112:155\u201372.","journal-title":"Methods Mol Med"},{"issue":"6","key":"1270_CR73","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/ijms17060765","volume":"17","author":"J Yang","year":"2016","unstructured":"Yang J, et al. MicroRNA-24 attenuates neointimal hyperplasia in the diabetic rat carotid artery injury model by inhibiting Wnt4 signaling pathway. Int J Mol Sci. 2016;17(6):765.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1270_CR74","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.gene.2016.04.027","volume":"586","author":"J Yang","year":"2016","unstructured":"Yang J, et al. MicroRNA-24 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1. Gene. 2016;586(2):268\u201373.","journal-title":"Gene"},{"issue":"12","key":"1270_CR75","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/sj.gt.3301695","volume":"9","author":"YK Lai","year":"2002","unstructured":"Lai YK, et al. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther. 2002;9(12):804\u201313.","journal-title":"Gene Ther"},{"issue":"21","key":"1270_CR76","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, et al. Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358(21):2240\u20138.","journal-title":"N Engl J Med"},{"issue":"21","key":"1270_CR77","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"JW Bainbridge","year":"2008","unstructured":"Bainbridge JW, et al. Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358(21):2231\u20139.","journal-title":"N Engl J Med"},{"issue":"21","key":"1270_CR78","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.1128\/JVI.01971-14","volume":"88","author":"MS Weinberg","year":"2014","unstructured":"Weinberg MS, et al. Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms. J Virol. 2014;88(21):12472\u201384.","journal-title":"J Virol"},{"issue":"3","key":"1270_CR79","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","volume":"172","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Release. 2013;172(3):962\u201374.","journal-title":"J Control Release"},{"issue":"4","key":"1270_CR80","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1517\/14712598.2016.1134480","volume":"16","author":"J Pahle","year":"2016","unstructured":"Pahle J, Walther W. Vectors and strategies for nonviral cancer gene therapy. Expert Opin Biol Ther. 2016;16(4):443\u201361.","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"1270_CR81","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/CIRCRESAHA.107.168682","volume":"103","author":"KP Malabanan","year":"2008","unstructured":"Malabanan KP, et al. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury. Circ Res. 2008;103(4):378\u201387.","journal-title":"Circ Res"},{"issue":"5","key":"1270_CR82","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/CIRCRESAHA.108.188425","volume":"104","author":"L Wang","year":"2009","unstructured":"Wang L, et al. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res. 2009;104(5):688\u201398.","journal-title":"Circ Res"},{"issue":"4","key":"1270_CR83","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jcb.25011","volume":"116","author":"J Lee","year":"2015","unstructured":"Lee J, et al. MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation. J Cell Biochem. 2015;116(4):598\u2013608.","journal-title":"J Cell Biochem"},{"issue":"6","key":"1270_CR84","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.cellsig.2014.12.022","volume":"27","author":"N Choe","year":"2015","unstructured":"Choe N, et al. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor. Cell Signal. 2015;27(6):1056\u201365.","journal-title":"Cell Signal"},{"issue":"2","key":"1270_CR85","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2013.05.009","volume":"229","author":"N Choe","year":"2013","unstructured":"Choe N, et al. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis. 2013;229(2):348\u201355.","journal-title":"Atherosclerosis"},{"issue":"11","key":"1270_CR86","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/81176","volume":"18","author":"BD Klugherz","year":"2000","unstructured":"Klugherz BD, et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol. 2000;18(11):1181\u20134.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1270_CR87","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1021\/bm0341834","volume":"4","author":"B Thierry","year":"2003","unstructured":"Thierry B, et al. Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromol. 2003;4(6):1564\u201371.","journal-title":"Biomacromol"},{"issue":"9","key":"1270_CR88","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1021\/bm0604808","volume":"7","author":"CM Jewell","year":"2006","unstructured":"Jewell CM, et al. Release of plasmid DNA from intravascular stents coated with ultrathin multilayered polyelectrolyte films. Biomacromol. 2006;7(9):2483\u201391.","journal-title":"Biomacromol"},{"issue":"5","key":"1270_CR89","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1016\/j.actbio.2013.01.013","volume":"9","author":"S Hossfeld","year":"2013","unstructured":"Hossfeld S, et al. Bioactive coronary stent coating based on layer-by-layer technology for siRNA release. Acta Biomater. 2013;9(5):6741\u201352.","journal-title":"Acta Biomater"},{"issue":"7","key":"1270_CR90","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/jbm.a.35357","volume":"103","author":"X Zhu","year":"2015","unstructured":"Zhu X, Braatz RD. A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion. J Biomed Mater Res A. 2015;103(7):2269\u201379.","journal-title":"J Biomed Mater Res A"},{"issue":"11","key":"1270_CR91","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1021\/bm700540p","volume":"8","author":"H Takahashi","year":"2007","unstructured":"Takahashi H, Letourneur D, Grainger DW. Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromol. 2007;8(11):3281\u201393.","journal-title":"Biomacromol"},{"issue":"32","key":"1270_CR92","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1016\/j.biomaterials.2006.07.016","volume":"27","author":"X Wang","year":"2006","unstructured":"Wang X, et al. Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials. 2006;27(32):5588\u201395.","journal-title":"Biomaterials"},{"issue":"41","key":"1270_CR93","first-page":"2938","volume":"89","author":"XF Qiu","year":"2009","unstructured":"Qiu XF, et al. Controlled release of siRNA nanoparticles loaded in a novel external stent prepared by emulsion electrospinning attenuates neointima hyperplasia in vein grafts. Zhonghua Yi Xue Za Zhi. 2009;89(41):2938\u201342.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"7","key":"1270_CR94","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s11427-015-4843-2","volume":"58","author":"L Zhang","year":"2015","unstructured":"Zhang L, et al. ADAMTS-7 promotes vascular smooth muscle cells proliferation in vitro and in vivo. Sci China Life Sci. 2015;58(7):674\u201381.","journal-title":"Sci China Life Sci"},{"key":"1270_CR95","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1479-5876-10-2","volume":"10","author":"J Sun","year":"2012","unstructured":"Sun J, et al. Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA. J Transl Med. 2012;10:2.","journal-title":"J Transl Med"},{"issue":"3","key":"1270_CR96","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jvs.2006.04.044","volume":"44","author":"H Banno","year":"2006","unstructured":"Banno H, et al. Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg. 2006;44(3):633\u201341.","journal-title":"J Vasc Surg"},{"key":"1270_CR97","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.116.022478","volume":"134","author":"D Hartmann","year":"2016","unstructured":"Hartmann D, et al. MicroRNA-based therapy of Gata2-deficient vascular disease. Circulation. 2016;134:1973\u201390.","journal-title":"Circulation"},{"issue":"9","key":"1270_CR98","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1096\/fj.201500163R","volume":"30","author":"J Lin","year":"2016","unstructured":"Lin J, et al. MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10. FASEB J. 2016;30(9):3216\u201326.","journal-title":"FASEB J"},{"issue":"6","key":"1270_CR99","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jvs.2009.08.050","volume":"50","author":"Y Qu","year":"2009","unstructured":"Qu Y, et al. VCAM-1 siRNA reduces neointimal formation after surgical mechanical injury of the rat carotid artery. J Vasc Surg. 2009;50(6):1452\u20138.","journal-title":"J Vasc Surg"},{"key":"1270_CR100","doi-asserted-by":"publisher","first-page":"25636","DOI":"10.1038\/srep25636","volume":"6","author":"J Chung","year":"2016","unstructured":"Chung J, et al. Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions-targeted siRNA delivery to pro-atherogenic endothelium in vivo. Sci Rep. 2016;6:25636.","journal-title":"Sci Rep"},{"issue":"1","key":"1270_CR101","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijpharm.2014.04.041","volume":"469","author":"NG Leus","year":"2014","unstructured":"Leus NG, et al. VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression. Int J Pharm. 2014;469(1):121\u201331.","journal-title":"Int J Pharm"},{"issue":"16","key":"1270_CR102","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/sj.gt.3302777","volume":"13","author":"A Santel","year":"2006","unstructured":"Santel A, et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther. 2006;13(16):1222\u201334.","journal-title":"Gene Ther"},{"issue":"1","key":"1270_CR103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1582-4934.2007.00006.x","volume":"11","author":"T Walker","year":"2007","unstructured":"Walker T, et al. Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection. J Cell Mol Med. 2007;11(1):139\u201347.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1270_CR104","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/mt.2013.291","volume":"22","author":"V Fehring","year":"2014","unstructured":"Fehring V, et al. Delivery of therapeutic siRNA to the lung endothelium via novel lipoplex formulation DACC. Mol Ther. 2014;22(4):811\u201320.","journal-title":"Mol Ther"},{"issue":"1\u20132","key":"1270_CR105","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijpharm.2016.10.049","volume":"515","author":"A Egorova","year":"2016","unstructured":"Egorova A, et al. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery. Int J Pharm. 2016;515(1\u20132):431\u201340.","journal-title":"Int J Pharm"},{"issue":"6","key":"1270_CR106","doi-asserted-by":"publisher","first-page":"e39123","DOI":"10.1371\/journal.pone.0039123","volume":"7","author":"M Bhasin","year":"2012","unstructured":"Bhasin M, et al. Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury. PLoS ONE. 2012;7(6):e39123.","journal-title":"PLoS ONE"},{"issue":"10","key":"1270_CR107","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1161\/01.ATV.0000183885.66153.8a","volume":"25","author":"GJ Wang","year":"2005","unstructured":"Wang GJ, et al. Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. Arterioscler Thromb Vasc Biol. 2005;25(10):2081\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1270_CR108","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2310\/6670.2007.00049","volume":"15","author":"AW Hoel","year":"2007","unstructured":"Hoel AW, et al. Regulation of vascular smooth muscle cell growth by survivin. Vascular. 2007;15(6):344\u20139.","journal-title":"Vascular"},{"issue":"4","key":"1270_CR109","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tcm.2006.02.002","volume":"16","author":"MS Conte","year":"2006","unstructured":"Conte MS, Altieri DC. Survivin regulation of vascular injury. Trends Cardiovasc Med. 2006;16(4):114\u20137.","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"1270_CR110","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jvs.2005.01.006","volume":"41","author":"HF Simosa","year":"2005","unstructured":"Simosa HF, et al. Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype. J Vasc Surg. 2005;41(4):682\u201390.","journal-title":"J Vasc Surg"},{"issue":"42","key":"1270_CR111","doi-asserted-by":"publisher","first-page":"25928","DOI":"10.1074\/jbc.271.42.25928","volume":"271","author":"JM Herbert","year":"1996","unstructured":"Herbert JM, et al. Protein kinase C alpha expression is required for heparin inhibition of rat smooth muscle cell proliferation in vitro and in vivo. J Biol Chem. 1996;271(42):25928\u201335.","journal-title":"J Biol Chem"},{"issue":"11","key":"1270_CR112","doi-asserted-by":"publisher","first-page":"e0141397","DOI":"10.1371\/journal.pone.0141397","volume":"10","author":"D Yu","year":"2015","unstructured":"Yu D, et al. MARCKS signaling differentially regulates vascular smooth muscle and endothelial cell proliferation through a KIS-, p27kip1- dependent mechanism. PLoS ONE. 2015;10(11):e0141397.","journal-title":"PLoS ONE"},{"issue":"10","key":"1270_CR113","doi-asserted-by":"publisher","first-page":"e002255","DOI":"10.1161\/JAHA.115.002255","volume":"4","author":"D Yu","year":"2015","unstructured":"Yu D, et al. Myristoylated alanine-rich protein kinase substrate (MARCKS) regulates small GTPase Rac1 and Cdc42 activity and is a critical mediator of vascular smooth muscle cell migration in intimal hyperplasia formation. J Am Heart Assoc. 2015;4(10):e002255.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1270_CR114","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1096\/fj.08-114173","volume":"23","author":"TS Monahan","year":"2009","unstructured":"Monahan TS, et al. MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein. FASEB J. 2009;23(2):557\u201364.","journal-title":"FASEB J"},{"issue":"1","key":"1270_CR115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3892\/mmr.2016.6020","volume":"15","author":"M Hao","year":"2017","unstructured":"Hao M, Li M, Li W. Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension. Mol Med Rep. 2017;15(1):160\u20138.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1270_CR116","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/nar\/gki193","volume":"33","author":"J Elmen","year":"2005","unstructured":"Elmen J, et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 2005;33(1):439\u201347.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-017-1270-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:53:13Z","timestamp":1589536393000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1270-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1270-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]},"assertion":[{"value":"15 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"164"}}